A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry

作者：Salter Amber^*; Thomas Nina P; Tyry Tuula; Cutter Gary R; Marrie Ruth Ann

来源：Multiple Sclerosis, 2018, 24(7): 951-962.

DOI：10.1177/1352458517711274

• Primary progressive multiple sclerosis
• survey
• disease attributes
• health care utilization
• comorbidities
• NARCOMS

Background: Primary progressive multiple sclerosis (PPMS) represents 10%-15% of all multiple sclerosis (MS) diagnoses. Information regarding socio-demographic and clinical characteristics of persons with PPMS is limited.
Objective: To characterize persons with PPMS in the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Methods: We compared demographic and health-related characteristics of NARCOMS Registry participants reporting PPMS in the spring 2015 update survey with those reporting relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS), with characteristics of published PPMS cohorts.
Results: Of 8004 responders, 6774 self-reported a clinical course of PPMS, SPMS, or RRMS. The PPMS cohort (n=632, 9.3%) reported a mean (standard deviation (SD)) age of 64.3 (8.9)years; 62.7% were female; the SPMS and RRMS cohorts were younger and had a higher proportion of females. The NARCOMS PPMS cohort differed in age, time from onset and diagnosis, and proportion of females compared to population-based and clinical trial cohorts. Median (25%, 75%) number of comorbidities was 2 (1, 2) for each cohort with vascular comorbidities being most frequently reported.
Conclusion: The NARCOMS population provides a different perspective on persons with PPMS than clinical trials. A better understanding of the characteristics of persons with PPMS may help address unmet needs in this population.

• 出版日期2018-6